Insider · CIK 0001537370
Rishi Gupta
Files at ELVN (Enliven Therapeutics, Inc.), TSBX (Turnstone Biologics Corp.). First filing -, latest -.
In brief
Rishi Gupta files SEC Form 4 as director and 10% owner at ELVN (Enliven Therapeutics, Inc.), and also at TSBX (Turnstone Biologics Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rishi Gupta has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 12, 2024 | VRNA Verona Pharma plc | 56,200 0.01% of outstanding | $894k | Mar 12, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +33,989 | $0.00 | $0 | 33,989 | Feb 17, 2026 |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,580 | $0.00 | $0 | 1,580 | Feb 17, 2026 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: See Footnotes | -3,099,265 | - | - | 0 | Aug 8, 2025 |
| Feb 6, 2025 | ELVN Enliven Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,491 | $0.00 | $0 | 20,491 | Feb 10, 2025 |
| Oct 16, 2023 | TSBX Turnstone Biologics Corp. | AGrant or award Stock Option (Right to Buy)derivative | +25,540 | $0.00 | $0 | 25,540 | Oct 17, 2023 |
Questions about Rishi Gupta
Answered from the filings on this page, as of the latest one.
Is Rishi Gupta buying or selling?
Rishi Gupta has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rishi Gupta's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rishi Gupta has 0.
Where does Rishi Gupta file Form 4?
Rishi Gupta has filed Form 4 at ELVN (Enliven Therapeutics, Inc.); TSBX (Turnstone Biologics Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.